IDEMIA launches a new generation of MorphoWave contactless fingerprint terminals

IDEMIA launches two new biometric terminals succeeding the award winning generation of MorphoWave™ Compact.

In the context of a global health crisis, implementating contactless authentication terminals is now crucial in many public and private spaces; allowing a faster, more secure, and barrier-free biometric authentication.

IDEMIA, the global leader in Augmented Identity, innovates to offer ever more complete and adapted solutions to its consumers. With MorphoWave™, users simply wave their hands in a quick and easy gesture to have their four fingerprints 3D-scanned and verified in less than one second.

Launched in 2016, the MorphoWave™ technology has proven a great success—it is powered through several generations with more than 15,000 gates throughout the world.

In 2022, two new versions will be available for worldwide deployment:

  • MorphoWave™ XP X-tended Performance provides a 20% increase in performance compared with the previous generation, itself recognized as one of the best in the world in the latest NIST rankings. It accomodates demanding deployments with up to 60 users per minute and up to 100,000 user records. Its large color display is ideal for brand customization and user interaction as well as time and attendance management use cases.
  • MorphoWave™ SP Simplified Profile, offers all the essence of MorphoWave to make IDEMIA space security solutions accessible to a larger number of players: smaller installations and companies with less demanding requirements with up to 40 users per minute and up to 10,000 user records.

Both versions leverage the “plug & play” features of Compact, including software integrations with 20 leading access control platforms as well as physical integrations with leading gates/turnstiles manufacturers to enable simpler and more cost-effective deployments.

These two new products incorporate the most advanced biometric algorithms we have ever created, continuing the tradition of our award-winning solutions in the market. We are the only manufacturer of physical access control terminals to undergo such rigorous testing, demonstrating the reliability of our solutions. We will continue to invest in research for greater accuracy and security.
Yves Portalier, Executive VP Biometric Devices at IDEMIA

MorphoWave SP and XP will be presented at the IDEMIA booth (S2-G32) during the Intersec 2022 tradeshow in Dubai from January 16 to 18, and will be commercially available in the course of January through our usual IDEMIA partners network.

  • About us - IDEMIA, the global leader in Augmented Identity, provides a trusted environment enabling citizens and consumers alike to perform their daily critical activities (such as pay, connect and travel) in the physical as well as digital space.

    Securing our identity has become mission critical in the world we live in today. By standing for Augmented Identity, an identity that ensures privacy and trust and guarantees secure, authenticated and verifiable transactions, we reinvent the way we think, produce, use and protect one of our greatest assets–our identity–whether for individuals or for objects, whenever and wherever security matters. We provide Augmented Identity for international clients from Financial, Telecom, Identity, Public Security and IoT sectors. With 15,000 employees around the world, IDEMIA serves clients in 180 countries.

your press contact(s).
IDEMIA
IDEMIA

Subscribe to our newsletter

Receive our key news and keep up with the trends in our markets by subscribing to our newsletter.

By clicking on the "Subscribe" button, you confirm that you agree to IDEMIA’s Terms of Use and Privacy Policy, and agree to the processing of your personal data and acknowledge your related rights, as described therein.

Your email address will be used exclusively by IDEMIA to send you newsletters related yo your selected topics of interest. In accordance with the law, you have rights of access, rectification and erasure of your personal data, as well as opposition of processing, which can be exercised by writing to dpo@idemia.com.